Viking Therapeutics (VKTX) Misses Q1 EPS by 8c

Viking Therapeutics (NASDAQ: VKTX) reported Q1 EPS of ($0.41), $0.08 worse than the analyst estimate of ($0.33).

For earnings history and earnings-related data on Viking Therapeutics (VKTX) click here.

You May Also Be Interested In

• Citrini flags overheating concerns as leverage, chip rally weigh on KOSPI
• Carnival Corp. (CCL) Tops Q2 EPS by 8c, Beats on Revenue; Offers Guidance
• Gelum Resources closes $4.3M private placement, hires geophysics firm